OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SIVM50

Shivam Chemicals Ltd

Fishing & FarmingVerified

Shivam Chemicals Ltd has a fully diluted share count of 16,987,000 shares, with no additional shares outstanding in the diluted structure, indicating no immediate dilution pressure from stock options or convertible instruments. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. Profitability and return metrics are not available for comparison against industry benchmarks, as the valuation snapshot does not include key financial ratios such as ROIC, EBITDA margins, or net profit margins. This lack of data limits the ability to assess the company's performance relative to its peers. The company's revenue concentration and geographic exposure are not disclosed in the available data, making it difficult to evaluate the risk associated with over-reliance on specific markets or customer segments. Growth trajectory is also unclear, as the outlook for the current and next fiscal years does not include numeric deltas or directional guidance. Without historical revenue data or forward-looking statements, it is challenging to determine the company's growth potential. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, but the absence of detailed financial disclosures limits the ability to evaluate long-term capital structure risks. Recent events, including filings or transcripts, are not available in the provided data, which restricts the ability to analyze management commentary or strategic shifts that may affect the company's performance.

30-day price · SIVM-9.15 (-7.8%)
Low$99.90High$117.90Close$108.75As of15 May, 00:00 UTC
Profile
CompanyShivam Chemicals Ltd
TickerSIVM.BO
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFishing & Farming
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Shivam Chemicals Ltd has a fully diluted share count of 16,987,000 shares, with no additional shares outstanding in the diluted structure, indicating no immediate dilution pressure from stock options or convertible instruments. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. Profitability and return metrics are not available for comparison against industry benchmarks, as the valuation snapshot does not include key financial ratios such as ROIC, EBITDA margins, or net profit margins. This lack of data limits the ability to assess the company's performance relative to its peers. The company's revenue concentration and geographic exposure are not disclosed in the available data, making it difficult to evaluate the risk associated with over-reliance on specific markets or customer segments. Growth trajectory is also unclear, as the outlook for the current and next fiscal years does not include numeric deltas or directional guidance. Without historical revenue data or forward-looking statements, it is challenging to determine the company's growth potential. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, but the absence of detailed financial disclosures limits the ability to evaluate long-term capital structure risks. Recent events, including filings or transcripts, are not available in the provided data, which restricts the ability to analyze management commentary or strategic shifts that may affect the company's performance.
Key takeaways
  • The company has no additional shares in the diluted structure, indicating no immediate dilution risk.
  • Liquidity risk cannot be assessed due to missing balance-sheet data and lack of going-concern language.
  • Profitability and return metrics are not available for comparison with industry benchmarks.
  • Revenue concentration and geographic exposure are not disclosed, limiting risk assessment.
  • Growth trajectory is unclear due to the absence of numeric outlooks or historical revenue data.
  • Recent events and management commentary are not available for analysis.
  • --
  • **RATIONALES**:
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$955.0M$15.4M$8.7M$9.1M
FY-3$1.78B$62.3M$44.4M$44.5M
FY-2$1.57B$49.9M$37.3M-$101.3M
FY-1$1.47B$21.9M$12.1M-$7.5M
FY0$2.24B$33.0M$20.9M$20.9M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$99.4M$52.8M$738.0k
FY-3$236.9M$97.1M$2.7M
FY-2$312.4M$133.5M$3.5M
FY-1$409.6M$150.6M$3.6M
FY0$584.7M$354.3M$7.6M
PeriodOCFCapExFCFSBC
FY-4$15.0M-$539.0k$9.1M
FY-3-$30.0M-$874.0k$44.5M
FY-2$89.0M-$139.4M-$101.3M
FY-1$49.5M-$31.0M-$7.5M
FY0-$146.1M-$12.9M$20.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6$1.6M
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6$409.6M$150.6M$3.6M
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6$49.5M-$31.0M$1.6M
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Food · cohort 409 companies
MetricSIVMActivity
Op margin4.0% medp25 -1.2% · p75 12.3%
Net margin2.7% medp25 -1.5% · p75 9.9%
Gross margin18.5% medp25 9.6% · p75 30.1%
CapEx / revenue-4.9% medp25 -11.1% · p75 -1.7%
Debt / equity42.1% medp25 9.3% · p75 109.2%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 00:15 UTC#2d784e98
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 11:04 UTCJob: dbebabf7